Singapore Clinical Trial: A Global, Phase 3, Randomized, Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of Firmonertinib Compared with Investigator’s Choice of Osimertinib or Afatinib as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic Non-Small-Cell Lung Cancer with Epidermal Growth Factor Receptor P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations (ALPACCA)

Singapore, March 27 -- The Health Sciences Authority received information related to the study titled 'A Global, Phase 3, Randomized, Multicenter, Open-Label Study to Evaluate the Efficacy and Safety ... Read More

Singapore Clinical Trial: A Phase 2 Randomized, Placebo-Controlled, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of MK-2214 in Participants with Early Alzheimer's Disease

Singapore, March 27 -- The Health Sciences Authority received information related to the study titled 'A Phase 2 Randomized, Placebo-Controlled, Double-Blind, Parallel-Group Study to Evaluate the Effi... Read More

Singapore Clinical Trial: Phase 2b, Randomized, Double-Blind, Placebo-Controlled Clinical Trial, Preceded by a Single Ascending Dose Portion and a Phase 2 Open-Label Portion, to Evaluate the Safety and Efficacy of Oral Infigratinib in Infants and Young Children with Achondroplasia

Singapore, March 27 -- The Health Sciences Authority received information related to the study titled 'Phase 2b, Randomized, Double-Blind, Placebo-Controlled Clinical Trial, Preceded by a Single Ascen... Read More

Singapore Clinical Trial: A Phase 3 Open-label Randomized Study Assessing the Efficacy and Safety of RLY-2608 + Fulvestrant Versus Capivasertib + Fulvestrant as Treatment for PIK3CA-mutant Hormone Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Locally Advanced or Metastatic Breast Cancer Following Recurrence or Progression On or After Treatment with a CDK4/6 Inhibitor

Singapore, March 27 -- The Health Sciences Authority received information related to the study titled 'A Phase 3 Open-label Randomized Study Assessing the Efficacy and Safety of RLY-2608 + Fulvestrant... Read More

'Sir, yeh memes band nahi hone chahiye': Raghav Chadha joins meme fest on his Parliament speeches

New Delhi, March 27 -- AAP MP Raghav Chadha on Friday said he was enjoying the wave of memes circulating about his recent interventions in the Rajya Sabha, many of which focus on everyday, consumer-re... Read More

पेट्रोल-डीजल पर सरकार का बड़ा फैसला, फिर भी तेल कंपनियों के शेयर धड़ाम

नई दिल्ली, मार्च 27 -- केंद्र सरकार ने पेट्रोल और डीजल को लेकर बड़ा फैसला किया है। यह फैसला पेट्रोल और डीजल पर लगने वाली स्पेशल एडिशनल एक्साइज ड्यूटी से जुड़ा है। केंद्र ने पेट्रोल पर लगने वाली स्पेशल... Read More

जन्म पत्री नहीं मानी जा सकती उम्र का सबूत, दिल्ली हाई कोर्ट ने सुनाया अहम फैसला; क्या कहा

दिल्ली, मार्च 27 -- दिल्ली हाई कोर्ट ने एक अहम फैसले में स्पष्ट किया है कि जन्म पत्री को किसी की जन्मतिथि का वैध प्रमाण नहीं माना जा सकता है। एक मामले मे कोर्ट ने 13 साल पुराने किडनैपिंग और रेप के माम... Read More

उत्तराखंड में स्कूल बसों के लिए नया किराया तय, एक अप्रैल से लागू होगा; देखें लिस्ट

देहरादून, मार्च 27 -- उत्तराखंड में स्कूल बस और वैन का मासिक किराया नए शैक्षिक सत्र यानी एक अप्रैल से लागू हो जाएगा। राज्य परिवहन प्राधिकरण (एसटीए) में किराया निर्धारण प्रस्ताव मंजूर होने के बाद परिवह... Read More

NEWS: SENS. SCHIFF, PADILLA JOIN KAINE, GALLEGO AND COLLEAGUES TO PRESS TRUMP ADMINISTRATION ABOUT DECISION TO EASE SANCTIONS ON RUSSIA AND IRAN

WASHINGTON, March 27 -- Sen. Adam Schiff issued the following press release: Today, U.S. Senators Adam Schiff and Alex Padilla (both D-Calif.) joined Senators Tim Kaine (D-Va.) and Ruben Gallego (D-A... Read More

Indonesia, China boost security ties amid global tensions

Jakarta, March 27 -- The Indonesian government has conveyed its readiness to enhance the strategic partnership between China's Ministry of State Security (MSS) and the State Intelligence Agency (BIN) ... Read More

• ««
• «
• 41587
• 41588
• 41589
• 41590
• 41591
• 41592
• 41593
• 41594
• 41595
• 41596
• »
• »»